Treatment Strategies - Hematology at the EBMT 2012 Congress

Addressing Two Critical Early Complications of HSCT: Current and Future Concepts for Prevention and Treatment of VOD and GvHD

Gentium Sponsored Satellite Symposium at the European Group for Blood and Marrow Transplantation (EBMT) Meeting, Geneva, Switzerland, April 1, 2012

Lecture 1 - Pathophysiology, Incidence and Outcome of VOD after HSCT: What have we Learned in 30 years?

Enric Carreras, Hospital Clinic Barcelona, Barcelona, Spain

Lecture 2 - Therapy for Established VOD: An Update on Defibrotide Treatment Studies

Dietger Niederwieser, University of Leipzig, Leipzig, Germany

Lecture 3 - Acute GvHD: What are the Causes and Consequences at a Cellular Level?

Ernst Holler, University Medical Center, Regensburg, Germany

Lecture 4 - Prevention of VOD and GvHD: What did we learn from the VOD defibrotide prevention trial?

Selim Corbacioglu, Children’s Hospital, Regensburg, Germany

BACK TO VIDEO PAGE